Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
2000 1
2003 2
2004 2
2006 1
2007 1
2008 2
2009 2
2010 7
2011 3
2012 8
2013 7
2014 2
2015 5
2016 5
2017 3
2018 3
2019 7
2020 12
2021 19
2022 22
2023 15
2024 4
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Results by year

Filters applied: . Clear all
Page 1
Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients.
Chen J, Levy A, Tian AL, Huang X, Cai G, Fidelle M, Rauber C, Ly P, Pizzato E, Sitterle L, Piccinno G, Liu P, Durand S, Mao M, Zhao L, Iebba V, Felchle H, Mallard de La Varende AL, Fischer JC, Thomas S, Greten TF, Jones JC, Monge C, Demaria S, Formenti S, Belluomini L, Dionisi V, Massard C, Blanchard P, Robert C, Quevrin C, Lopes E, Clémenson C, Mondini M, Meziani L, Zhan Y, Zeng C, Cai Q, Morel D, Sun R, Laurent PA, Mangoni M, Di Cataldo V, Arilli C, Trommer M, Wegen S, Neppl S, Riechelmann RP, Camandaroba MP, Neto ES, Fournier PE, Segata N, Holicek P, Galluzzi L, Buqué A, Alves Costa Silva C, Derosa L, Kroemer G, Chen C, Zitvogel L, Deutsch E. Chen J, et al. Among authors: di cataldo v. Cancer Cell. 2025 Mar 10;43(3):361-379.e10. doi: 10.1016/j.ccell.2025.02.010. Cancer Cell. 2025. PMID: 40068595 Free article.
Nilotinib.
Quintás-Cardama A, Kim TD, Cataldo V, le Coutre P. Quintás-Cardama A, et al. Among authors: cataldo v. Recent Results Cancer Res. 2010;184:103-17. doi: 10.1007/978-3-642-01222-8_8. Recent Results Cancer Res. 2010. PMID: 20072834 Review.
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO).
Francolini G, Allegra AG, Detti B, Di Cataldo V, Caini S, Bruni A, Ingrosso G, D'Angelillo RM, Alitto AR, Augugliaro M, Triggiani L, Parisi S, Facchini G, Banini M, Simontacchi G, Desideri I, Meattini I, Valicenti RK, Livi L; ARTO Working Group members. Francolini G, et al. Among authors: di cataldo v. J Clin Oncol. 2023 Dec 20;41(36):5561-5568. doi: 10.1200/JCO.23.00985. Epub 2023 Sep 21. J Clin Oncol. 2023. PMID: 37733977 Clinical Trial.
HPV-Negative Cervical Cancer: A Narrative Review.
Arezzo F, Cormio G, Loizzi V, Cazzato G, Cataldo V, Lombardi C, Ingravallo G, Resta L, Cicinelli E. Arezzo F, et al. Among authors: cataldo v. Diagnostics (Basel). 2021 May 26;11(6):952. doi: 10.3390/diagnostics11060952. Diagnostics (Basel). 2021. PMID: 34073478 Free PMC article. Review.
Choline PET/CT in recurrent prostate cancer.
Detti B, Carnevale MG, Lucidi S, Burchini L, Caini S, Orsatti C, Bertini N, Roghi M, di Cataldo V, Fondelli S, Ingrosso G, Francolini G, Scartoni D, Sardaro A, Pisani A, Scoccianti S, Aristei C, Livi L. Detti B, et al. Among authors: di cataldo v. Front Oncol. 2023 Mar 21;13:1079808. doi: 10.3389/fonc.2023.1079808. eCollection 2023. Front Oncol. 2023. PMID: 37025599 Free PMC article.
In Reply to Guler and Onal.
Francolini G, Di Cataldo V, Detti B, Livi L. Francolini G, et al. Among authors: di cataldo v. Clin Oncol (R Coll Radiol). 2022 Jan;34(1):e84-e85. doi: 10.1016/j.clon.2021.11.007. Epub 2021 Nov 26. Clin Oncol (R Coll Radiol). 2022. PMID: 34844864 No abstract available.
Role of chemotherapy in nasopharyngeal carcinoma.
Paiar F, Di Cataldo V, Zei G, Pasquetti EM, Cecchini S, Meattini I, Mangoni M, Agresti B, Iermano C, Bonomo P, Biti G. Paiar F, et al. Among authors: di cataldo v. Oncol Rev. 2012 Jan 5;6(1):e1. doi: 10.4081/oncol.2012.e1. eCollection 2012 Mar 5. Oncol Rev. 2012. PMID: 25992199 Free PMC article. Review.
Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719).
Francolini G, Bertini N, Di Cataldo V, Garlatti P, Aquilano M, Caini S, Bruni A, Ingrosso G, D'angelillo RM, Tagliaferri L, Augugliaro M, Triggiani L, Parisi S, Timon G, Arcidiacono F, Marvaso G, Jereczek-Fossa BA, Lancia A, Franzese C, Alongi F, Simontacchi G, Greto D, Bonomo P, Loi M, Frosini G, Burchini L, Desideri I, Meattini I, Valicenti RK, Livi L. Francolini G, et al. Among authors: di cataldo v. Prostate Cancer Prostatic Dis. 2025 Dec;28(4):908-912. doi: 10.1038/s41391-025-00950-3. Epub 2025 Feb 19. Prostate Cancer Prostatic Dis. 2025. PMID: 39972049 Clinical Trial.
Kaposi's Sarcoma of the Oral Cavity.
Kennedy-LeJeune E, Cataldo VD. Kennedy-LeJeune E, et al. Among authors: cataldo vd. N Engl J Med. 2017 Mar 30;376(13):1268. doi: 10.1056/NEJMicm1611553. N Engl J Med. 2017. PMID: 28355516 Free article. No abstract available.
127 results